Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 3/2008

01.05.2008 | Clinical Investigation

Impact of Catheter Arteriography on the Serum Level of Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase

verfasst von: Ugur Bozlar, Mehmet Sahin Ugurel, Omer Ozcan, Erdinc Cakir, Bahri Ustunsoz, Taner Ucoz, Cumhur Bilgi, Ibrahim Somuncu

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to investigate the instantaneous impact of catheter arteriography on blood asymmetric dimethylarginine (ADMA) levels in accordance with patient- and procedure-related variables. Sixty-eight patients (16 women, 52 men; mean age, 45.6 ± 20.1 years; range, 20–79 years) referred for cerebral or peripheral catheter arteriography were recruited for the study. Pre- and postarteriography arterial blood ADMA levels were determined by high-performance liquid chromatographic technique. Type of nonionic iodinated contrast media used, duration of procedure, patient gender, and patient age were noted and evaluated as possible factors that could influence serum ADMA levels in arteriography procedures. Prearteriography ADMA levels decreased significantly after arteriography in general (pre, 1.16 ± 0.96 μmol/L; post, 1.08 ± 0.80 μmol/L; = 0.002). Males tended to have lower postarteriography serum ADMA levels (= 0.005). Serum ADMA levels tended to get lower after peripheral arteriography procedures (p = 0.005) and when iohexol, 350 mg I/ml, was used as the contrast agent (= 0.017). In conclusion, ADMA level does not seem to be subject to acute elevation after catheter arteriography; on the contrary, its level may decrease in general. Moreover, a reduction in serum ADMA level may be expected, especially in male patients, in patients who undergo a peripheral arteriography procedure, or when iohexol, 350 mg I/ml, is used as the contrast agent.
Literatur
1.
Zurück zum Zitat Kielstein JT, Impraim B, Simmel S et al (2004) Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 109(2):172–177PubMedCrossRef Kielstein JT, Impraim B, Simmel S et al (2004) Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 109(2):172–177PubMedCrossRef
2.
Zurück zum Zitat Cooke JP, Dzau VJ (1997) Nitric oxide synthase:role in the genesis of vascular disease. Annu Rev Med 48:489–509PubMedCrossRef Cooke JP, Dzau VJ (1997) Nitric oxide synthase:role in the genesis of vascular disease. Annu Rev Med 48:489–509PubMedCrossRef
3.
Zurück zum Zitat Boger RH (2003) The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res 59(4):824–833PubMedCrossRef Boger RH (2003) The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res 59(4):824–833PubMedCrossRef
4.
Zurück zum Zitat Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329(27):2002–2012PubMedCrossRef Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329(27):2002–2012PubMedCrossRef
5.
Zurück zum Zitat McCarty MF (2004) Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine-an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction. Med Hypoth 63(4):699–708CrossRef McCarty MF (2004) Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine-an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction. Med Hypoth 63(4):699–708CrossRef
6.
Zurück zum Zitat Dayoub H, Achan V, Adimoolam S et al (2003) Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation 108(24):3042–3047PubMedCrossRef Dayoub H, Achan V, Adimoolam S et al (2003) Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation 108(24):3042–3047PubMedCrossRef
7.
Zurück zum Zitat Böger RH (2004) Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the “L-arginine paradox” and acts as a novel cardiovascular risk factor. J Nutr 134(Suppl 10):2842S–2847SPubMed Böger RH (2004) Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the “L-arginine paradox” and acts as a novel cardiovascular risk factor. J Nutr 134(Suppl 10):2842S–2847SPubMed
8.
Zurück zum Zitat Baylis C (2006) Nitric oxide deficiency in chronic renal disease. Eur J Clin Pharmacol 62(Suppl):123–130CrossRef Baylis C (2006) Nitric oxide deficiency in chronic renal disease. Eur J Clin Pharmacol 62(Suppl):123–130CrossRef
9.
Zurück zum Zitat Tran CT, Leiper JM, Vallance P (2003) The DDAH/ADMA/NOS pathway. Atheroscler Suppl 4(4):33–40PubMedCrossRef Tran CT, Leiper JM, Vallance P (2003) The DDAH/ADMA/NOS pathway. Atheroscler Suppl 4(4):33–40PubMedCrossRef
10.
Zurück zum Zitat Valkonen VP, Paiva H, Salonen JT et al (2001) Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358(9299):2127–2128PubMedCrossRef Valkonen VP, Paiva H, Salonen JT et al (2001) Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358(9299):2127–2128PubMedCrossRef
11.
Zurück zum Zitat Surdacki A, Nowicki M, Sandmann J et al (1999) Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol 33(4):652–658PubMedCrossRef Surdacki A, Nowicki M, Sandmann J et al (1999) Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol 33(4):652–658PubMedCrossRef
12.
Zurück zum Zitat Böger RH, Bode-Böger SM, Thiele W et al (1997) Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95(8):2068–2074PubMed Böger RH, Bode-Böger SM, Thiele W et al (1997) Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95(8):2068–2074PubMed
13.
Zurück zum Zitat Böger RH, Bode-Böger SM, Szuba A et al (1998) Asymmetric dimethylarginine (ADMA) a novel risk factor for endothelial dysfunction its role in hypercholesterolemia. Circulation 98(18):1842–1847PubMed Böger RH, Bode-Böger SM, Szuba A et al (1998) Asymmetric dimethylarginine (ADMA) a novel risk factor for endothelial dysfunction its role in hypercholesterolemia. Circulation 98(18):1842–1847PubMed
14.
Zurück zum Zitat Sydow K, Schwedhelm E, Arakawa N et al (2003) ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of l-arginine and B vitamins. Cardiovasc Res 57(1):244–252PubMedCrossRef Sydow K, Schwedhelm E, Arakawa N et al (2003) ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of l-arginine and B vitamins. Cardiovasc Res 57(1):244–252PubMedCrossRef
15.
Zurück zum Zitat Usui M, Matsuoka H, Miyazaki H et al (1998) Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci 62(26):2425–2430PubMedCrossRef Usui M, Matsuoka H, Miyazaki H et al (1998) Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci 62(26):2425–2430PubMedCrossRef
16.
Zurück zum Zitat Yoo JH, Lee SC (2001) Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. Atherosclerosis 158(2):425–430PubMedCrossRef Yoo JH, Lee SC (2001) Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. Atherosclerosis 158(2):425–430PubMedCrossRef
17.
Zurück zum Zitat Gorenflo M, Zheng C, Werle E et al (2001) Plasma levels of asymmetrical dimethyl-L-arginine in patients with congenital heart disease and pulmonary hypertension. J Cardiovasc Pharmacol 37(4):489–492PubMedCrossRef Gorenflo M, Zheng C, Werle E et al (2001) Plasma levels of asymmetrical dimethyl-L-arginine in patients with congenital heart disease and pulmonary hypertension. J Cardiovasc Pharmacol 37(4):489–492PubMedCrossRef
18.
Zurück zum Zitat Kielstein JT, Böger RH, Bode-Böger SM et al (1999) Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10(3):594–600PubMed Kielstein JT, Böger RH, Bode-Böger SM et al (1999) Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10(3):594–600PubMed
19.
Zurück zum Zitat Saitoh M, Osanai T, Kamada T et al (2003) High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure:role in reduction of plasma nitric oxide level. Heart Vessels 18(4):177–182PubMedCrossRef Saitoh M, Osanai T, Kamada T et al (2003) High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure:role in reduction of plasma nitric oxide level. Heart Vessels 18(4):177–182PubMedCrossRef
20.
Zurück zum Zitat Fard A, Tuck CH, Donis JA et al (2000) Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol 20(9):2039–2044PubMed Fard A, Tuck CH, Donis JA et al (2000) Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol 20(9):2039–2044PubMed
21.
Zurück zum Zitat Bae SW, Stuhlinger MC, Yoo HS et al (2005) Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment. Am J Cardiol 95(6):729–733PubMedCrossRef Bae SW, Stuhlinger MC, Yoo HS et al (2005) Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment. Am J Cardiol 95(6):729–733PubMedCrossRef
22.
Zurück zum Zitat Steinberg HO, Paradisi G, Hook G et al (2000) Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 49(7):1231–1238PubMedCrossRef Steinberg HO, Paradisi G, Hook G et al (2000) Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 49(7):1231–1238PubMedCrossRef
23.
Zurück zum Zitat Azuma H, Sato J, Hamasaki H et al (1995) Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L-arginine in regenerated endothelial cells. Br J Pharmacol 115(6):1001–1004PubMed Azuma H, Sato J, Hamasaki H et al (1995) Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L-arginine in regenerated endothelial cells. Br J Pharmacol 115(6):1001–1004PubMed
24.
Zurück zum Zitat Boger RH, Sydow K, Borlak J et al (2000) LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res 87(2):99–105PubMed Boger RH, Sydow K, Borlak J et al (2000) LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res 87(2):99–105PubMed
25.
Zurück zum Zitat Osanai T, Saitoh M, Sasaki S et al (2003) Effect of shear stress on asymmetric dimethylarginine release from vascular endothelial cells. Hypertension 42(5):985–990PubMedCrossRef Osanai T, Saitoh M, Sasaki S et al (2003) Effect of shear stress on asymmetric dimethylarginine release from vascular endothelial cells. Hypertension 42(5):985–990PubMedCrossRef
26.
Zurück zum Zitat Chen BM, Xia LW, Zhao RQ (1997) Determination of NG, NG-dimethylarginine in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 692(2):467–471PubMedCrossRef Chen BM, Xia LW, Zhao RQ (1997) Determination of NG, NG-dimethylarginine in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 692(2):467–471PubMedCrossRef
27.
Zurück zum Zitat Lancaster JR Jr (1994) Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci USA 91(17):8137–8141PubMedCrossRef Lancaster JR Jr (1994) Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci USA 91(17):8137–8141PubMedCrossRef
28.
Zurück zum Zitat Balbatun A, Louka FR, Malinski T (2003) Dynamics of nitric oxide release in the cardiovascular system. Acta Biochim Pol 50(1):61–68PubMed Balbatun A, Louka FR, Malinski T (2003) Dynamics of nitric oxide release in the cardiovascular system. Acta Biochim Pol 50(1):61–68PubMed
29.
Zurück zum Zitat Wykretowicz A, Dziarmaga M, Szczepanik A et al (2003) Prospective evaluation of hydroperoxide plasma levels and stable nitric oxide end products in patients subjected to angioplasty for coronary artery disease. Int J Cardiol 89(2–3):173–178PubMedCrossRef Wykretowicz A, Dziarmaga M, Szczepanik A et al (2003) Prospective evaluation of hydroperoxide plasma levels and stable nitric oxide end products in patients subjected to angioplasty for coronary artery disease. Int J Cardiol 89(2–3):173–178PubMedCrossRef
30.
Zurück zum Zitat Clowes AW, Clowes MM, Fingerle J et al (1989) Kinetics of cellular proliferation after arterial injury. V. Role of acute distension in the induction of smooth muscle proliferation. Lab Invest 60(3):360–364PubMed Clowes AW, Clowes MM, Fingerle J et al (1989) Kinetics of cellular proliferation after arterial injury. V. Role of acute distension in the induction of smooth muscle proliferation. Lab Invest 60(3):360–364PubMed
31.
Zurück zum Zitat Iwashina M, Shichiri M, Marumo F et al (1998) Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells. Circulation 98(12):1212–1218PubMed Iwashina M, Shichiri M, Marumo F et al (1998) Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells. Circulation 98(12):1212–1218PubMed
32.
Zurück zum Zitat Janero DR, Ewing JF (2000) Nitric oxide and postangioplasty restenosis: pathological correlates and therapeutic potential. Free Radic Biol Med 29(12):1199–1221PubMedCrossRef Janero DR, Ewing JF (2000) Nitric oxide and postangioplasty restenosis: pathological correlates and therapeutic potential. Free Radic Biol Med 29(12):1199–1221PubMedCrossRef
33.
Zurück zum Zitat Yao S, Ober JC, Krishnaswami A et al (1992) Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation 86(4):1302–1309PubMed Yao S, Ober JC, Krishnaswami A et al (1992) Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation 86(4):1302–1309PubMed
34.
Zurück zum Zitat Hutcheson IR, Griffith TM, Pitman MR et al (1999) Iodinated radiographic contrast media inhibit shear stress- and agonist-evoked release of NO by the endothelium. Br J Pharmacol 128(2):451–457PubMedCrossRef Hutcheson IR, Griffith TM, Pitman MR et al (1999) Iodinated radiographic contrast media inhibit shear stress- and agonist-evoked release of NO by the endothelium. Br J Pharmacol 128(2):451–457PubMedCrossRef
35.
Zurück zum Zitat Furuta W, Yamauchi A, Dohgu S et al (2002) Contrast media increase vascular endothelial permeability by inhibiting nitric-oxide production. Invest Radiol 37(1):13–19PubMedCrossRef Furuta W, Yamauchi A, Dohgu S et al (2002) Contrast media increase vascular endothelial permeability by inhibiting nitric-oxide production. Invest Radiol 37(1):13–19PubMedCrossRef
36.
Zurück zum Zitat Zhang H, Holt CM, Malik N et al (2000) Effects of radiographic contrast media on proliferation and apoptosis of human vascular endothelial cells. Br J Radiol 73(874):1034–1041PubMed Zhang H, Holt CM, Malik N et al (2000) Effects of radiographic contrast media on proliferation and apoptosis of human vascular endothelial cells. Br J Radiol 73(874):1034–1041PubMed
37.
Zurück zum Zitat Baile EM, Pare PD, D’yachkova Y et al (1999) Effect of contrast media on coronary vascular resistance: contrast-induced coronary vasodilatation. Chest 116(4):1039–1045PubMedCrossRef Baile EM, Pare PD, D’yachkova Y et al (1999) Effect of contrast media on coronary vascular resistance: contrast-induced coronary vasodilatation. Chest 116(4):1039–1045PubMedCrossRef
Metadaten
Titel
Impact of Catheter Arteriography on the Serum Level of Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase
verfasst von
Ugur Bozlar
Mehmet Sahin Ugurel
Omer Ozcan
Erdinc Cakir
Bahri Ustunsoz
Taner Ucoz
Cumhur Bilgi
Ibrahim Somuncu
Publikationsdatum
01.05.2008
Verlag
Springer-Verlag
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 3/2008
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-008-9312-x

Weitere Artikel der Ausgabe 3/2008

CardioVascular and Interventional Radiology 3/2008 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.